- ►cancerkansas.org [PDF] C Dube, A Rostom, G Lewin, A Tsertsvadze, … - Annals of internal medicine, 2007 - Am Coll Physicians From the University of Calgary, Calgary, Alberta, Canada, and Children's
Hospital of Eastern Ontario Research Institute, University of Ottawa, and
Carleton University, Ottawa, Ontario, Canada. ... Background: Aspirin for ... Cited by 70 - Related articles - BL Direct - All 8 versions
- ►annals.org A Rostom, C Dubé, G Lewin, A Tsertsvadze, … - Annals of internal medicine, 2007 - Am Coll Physicians From University of Calgary, Calgary, Alberta, Canada, and Chalmers Research
Group, Children's Hospital of Eastern Ontario Research Institute, University of
Ottawa, and Carleton University, Ottawa, Ontario, Canada. Cited by 72 - Related articles - BL Direct - All 8 versions
- ►thelancet.com E Flossmann, PM Rothwell - The Lancet, 2007 - Elsevier We studied the effect of aspirin in two large randomised trials with reliable
post-trial follow-up for more than 20 years: the British Doctors Aspirin Trial
(N=5139, two-thirds allocated 500 mg aspirin for 5 years, a third to open ... Cited by 66 - Related articles - All 30 versions
J Cuzick, F Otto, JA Baron, PH Brown, J Burn … - Lancet Oncology, 2009 - Elsevier Evidence clearly shows a chemopreventive effect for aspirin and other
non-steroidal anti-inflammatory drugs (NSAIDs) on colorectal cancer and probably
other cancer types; however, data on the risk–benefit profile for cancer ... Cited by 10 - Related articles - All 23 versions
- ►nih.gov AT Chan, EL Giovannucci, JA Meyerhardt, … - Jama, 2005 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 129 - Related articles - BL Direct - All 8 versions
NR Cook, I Lee… - Jama, 2005 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Basic research ... Cited by 194 - Related articles - All 5 versions
JA Baron, RS Sandler, RS Bresalier, H Quan, … - Gastroenterology, 2006 - Elsevier Adenomas are recognized precursors to most colorectal cancers, and the
epidemiology of adenomas closely resembles that for colorectal cancer itself. 13
Prevention of adenomas is likely to prevent colorectal cancer, and adenomas ... Cited by 110 - Related articles - All 9 versions
- ►oxfordjournals.org M Allison, C Garland, R Chlebowski, M Criqui, … - American journal of epidemiology, 2006 - Oxford Univ Press The purpose of this study was to test the hypothesis that aspirin use is
associated with a decreased risk of incident colorectal cancer. From the Women's
Health Initiative, 91,574 participants between the ages of 50 and 79 years ... Cited by 11 - Related articles - BL Direct - All 7 versions
- ►emekmed.com [PDF] RFA Logan, MJ Grainge, VC Shepherd, NC … - Gastroenterology, 2007 - Elsevier Background & Aims: Although observational studies have found regular aspirin use
to be associated with a reduced risk of colorectal neoplasia, results from
randomized trials using aspirin have been inconsistent. Dietary folate ... Cited by 48 - Related articles - All 28 versions
A Mahipal, KE Anderson, PJ Limburg, AR … - Cancer Epidemiology Biomarkers & Prevention, 2006 - AACR Results: For colon cancer, the multivariable-adjusted hazard ratios (HR) for
women reporting use of aspirin two to five times and six or more times weekly
(compared with nonusers of aspirin) were 0.79 [95% confidence interval (95% ... Cited by 13 - Related articles - BL Direct - All 4 versions
